When it comes to pharmacology, the big story these days is the development of the “glucagon-like peptide-1 (GLP-1) mimics,” the first truly effective medications to treat obesity. It’s a fascinating story to be sure, but get set for a bumpy ride.
GLP-1 agonists
Mark and I began our conversation by reflecting on historical medical achievements, highlighting the transformative impact of vaccines, especially the Salk polio vaccine, and the remarkable progress in open-heart surgery.
ACSH relies on donors like you. If you enjoy our work, please contribute.
Make your tax-deductible gift today!
Popular articles
ACSH Podcasts
